Federal award
ABBOTT RAPID DX NORTH AMERICA LLC
SPE2DS22F0103
Contract
Obligated and Ceiling
- Obligated (net)
- $825,000.00
- Ceiling (potential value, not spending)
- $825,000.00
- Current value
- $825,000.00
- Gross positive obligations
- $825,000.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ABBOTT RAPID DX NORTH AMERICA LLC · P782RNU1NNK3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ABBOTT LABORATORIES · EF9EAJ1MF6U3
- Awarding agency
- Department of Defense · sub-agency 97AS · office SPE2DS
- Funding agency
- Department of Defense · sub-agency 97AS
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- SPE2DS22F0103
- Parent vehicle (IDV PIID)
- SPE2DE21D0053
- Award type code
- C
- Actions
- 1 · Jan 7, 2022 to Jan 7, 2022
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History1
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jan 7, 2022 | FY2022 | 0 | — | $825,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.